Eisai Co Ltd
-
Business
Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in…
Read More » -
Health News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
[ad_1] A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that…
Read More » -
Health News
Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma
[ad_1] Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts…
Read More » -
Business
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined…
Read More » -
Health News
More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study
[ad_1] Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical…
Read More » -
Health News
These health-care companies see opportunity ahead from Alzheimer’s drug approval
[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs, blood tests and other…
Read More »